Related Experiment Video
Updated: May 15, 2025

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Rhodosporidium toruloides-a new surrogate model to study rapamycin induced effects on human aging and cancer
Philipp M Cavelius1, Martina Haack1, Dania Awad1
1Department of Chemistry, Werner Siemens-Chair of Synthetic Biotechnology, Technical University of Munich (TUM), Garching, Germany.
Abstract:
The haploid, olegenious yeast Rhodosporidium toruloides accumulates intracellular lipids and carotenoids upon metabolic stress. Target of Rapamycin (TOR) signaling, essential for cell proliferation, is known to affect cellular lipid accumulation. In contrast to the conventional surrugate cell model S. cerevisiae, which harbours two TOR kinases within its TOR complex, R. toruloides only harbours one TOR kinase, mimicking mammalian systems. We used a proteomics centered approach to probe the cellular response, of the two R. toruloides haplotypes, IFO0559 and IFO0880 upon treatment with the TOR inhibitor rapamycin, with an original focus on difference in carotenoid and lipid accumulation. Unexpectedly, IFO0880 displayed severe growth arrest in response to rapamycin, while IFO0559 did not. Proteomic anaysis revealed differential expression of several proteins involved in cell cycle control, lipogensis, amino acid metabolism and autophagy between the two haplotypes. Among those we identified several proteins previously described in both mammalian oncogenic and aging contexts. This differential haplotype response to rapamycin treatment positions R. toruloides as a promising cell surrugate model to study cellular mechanisms underlying rapamycin response especially for systems with high lipid contents, an emerging hallmark of different forms of mammalian cancer and age related disease.
Insights
Rhodosporidium toruloides yeast, a model for studying cellular lipid accumulation, shows differential responses to the Target of Rapamycin (TOR) inhibitor rapamycin between its two haplotypes, IFO0559 and IFO0880.
Area of Science:
- Microbiology
- Biochemistry
- Cell Biology
Background:
- Rhodosporidium toruloides is an oleaginous yeast known for accumulating lipids and carotenoids under stress.
- Target of Rapamycin (TOR) signaling regulates cellular lipid accumulation and is crucial for cell proliferation.
- R. toruloides possesses a single TOR kinase, unlike S. cerevisiae, making it a relevant model for mammalian systems.
Purpose of the Study:
- To investigate the differential cellular response of two R. toruloides haplotypes (IFO0559 and IFO0880) to rapamycin treatment.
- To analyze differences in lipid and carotenoid accumulation and proteomic profiles between haplotypes.
- To evaluate R. toruloides as a model for studying rapamycin response in lipid-rich systems relevant to cancer and aging.
Main Methods:
- Proteomics-centered approach.
- Treatment of R. toruloides haplotypes IFO0559 and IFO0880 with the TOR inhibitor rapamycin.
- Analysis of differential protein expression, lipid accumulation, and carotenoid production.
Main Results:
- One haplotype (IFO0880) exhibited severe growth arrest upon rapamycin treatment, while the other (IFO0559) did not.
- Proteomic analysis revealed differential expression of proteins involved in cell cycle control, lipogenesis, amino acid metabolism, and autophagy.
- Identified proteins with known roles in mammalian oncogenesis and aging.
Conclusions:
- R. toruloides exhibits haplotype-specific responses to rapamycin, highlighting the importance of genetic background.
- The differential response suggests R. toruloides can serve as a valuable model for studying rapamycin's effects on lipid metabolism.
- This yeast model is promising for investigating cellular mechanisms in cancer and age-related diseases characterized by high lipid content.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Replicative Cell Senescence

